POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
Abstract
Authors
S Mouallif K Thomas NE Adlard P Cooney F Blanchette BP Patel M Baharnoori V Bhan F Clift D Grima